Champions Oncology Inc reports results for the quarter ended in July - Earnings Summary

Champions Oncology

13/09/2023 23:33

* Champions Oncology Inc  CSBR.OQ  reported a quarterly
adjusted
loss of 19 cents​​ per share for the quarter ended in July. The
mean expectation of two analysts for the quarter was for a loss
of 10 cents per share.
    * Revenue fell 8.6% to $12.56 million from a year ago;
analysts
expected $13.06 million. 
    * Champions Oncology Inc's reported EPS for the quarter was
a loss
of 19 cents​.
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Champions Oncology Inc shares had risen by 3.0% this
quarter and
gained 45.7% so far this year.
    * The company reported a quarterly loss of $2.57 million.
    * Wall Street's median 12-month price target for Champions
Oncology Inc is $9.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
September 13 at 10:33 p.m. UTC. ​All figures in US dollars
unless otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jul. 31 2023      -0.10          -0.19          Missed
 Apr. 30 2023      -0.12          -0.19          Missed
 Jan. 31 2023      -0.03          -0.18          Missed
 Oct. 31 2022      -0.01          0.00           Beat